bell
The current prices are delayed by 15 mins, login to check live prices.
Sun Pharma Advanced Research Company Ltd share price logo

Sun Pharma Advanced Research Company Ltd

(SPARC)

₹218.250.68%

as on 04:01PM, 19 Sep 2024

Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹215.26
    ₹221.9
  • 52 Week's Low

    52 Week's High

    ₹196.1
    ₹472.8
1 Month Return+ 3.41 %
3 Month Return-5.68 %
1 Year Return-5.02 %
Previous Close₹219.74
Open₹221.40
Volume6.30L
Upper Circuit-
Lower Circuit-
Market Cap₹7,131.04Cr

Key Statistics

P/E Ratio-18.39
PEG Ratio2.85
Market Cap₹7,131.04 Cr
P/B Ratio96.09
EPS-11.93
Dividend Yield0
SectorPharmaceuticals
ROE0

Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹7,131.04 Cr8.69%0.79-₹388 Cr₹75 Cr
HOLD₹29,141.32 Cr115.85%0.52₹300 Cr₹1,051 Cr
BUY₹19,095.29 Cr32.86%0.57₹72 Cr₹6,702 Cr
BUY₹13,121.49 Cr37.4%0.68₹218 Cr₹1,296 Cr
BUY₹25,351.51 Cr217.69%0.55₹258 Cr₹1,375 Cr

Company Information

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Share Price: ₹218.25 per share as on 19 Sep, 2024 04:01 PM
Market Capitalisation: ₹7,131.04Cr as of today
Revenue: ₹16.81Cr as on June 2024 (Q2 24)
Net Profit: ₹-95.90Cr as on June 2024 (Q2 24)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSun Pharma Advanced Research Company Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Company Ltd Stock Drops 42% - 13 Jul, 2024

    Sun Pharma Advanced Research Company Ltd stock has dropped by 42% in the last quarter, with revenue shrinking by 1.5% per year over the past five years. Despite this, the stock is up 9% each year during the same period and provided a TSR of 3.9% over the last twelve months.

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 30.28% to 31.51% in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 142.7% return, outperforming this stock by 165.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 78.3% return, outperforming this stock by 83.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 3.23% to 2.64% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, SPARC stock has moved down by -38.8%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 0.25% to 0.08% in Jun 2024 quarter

Company Financials

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹23.95Cr (-)₹21.18Cr (↓11.57%)₹13.86Cr (↓34.56%)₹16.56Cr (↑19.48%)₹16.81Cr (↑1.51%)
Net Income-₹95.35Cr (-)-₹86.42Cr (↓9.37%)-₹99.65Cr (↑15.31%)-₹105.79Cr (↑6.16%)-₹95.90Cr (↓9.35%)
Net Profit Margin-398.12% (-)-408.03% (↑2.49%)-718.98% (↑76.21%)-638.83% (↓11.15%)-570.49% (↓10.70%)
Value in ₹ crore
Details2021202220232024
Total Assets₹229.70Cr (-)₹280.08Cr (↑21.93%)₹830.12Cr (↑196.39%)₹486.34Cr (↓41.41%)
Total Liabilities₹397.95Cr (-)₹248.85Cr (↓37.47%)₹317.35Cr (↑27.53%)₹361.49Cr (↑13.91%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹210.81Cr (-)-₹151.90Cr (↓27.94%)-₹208.23Cr (↑37.08%)-₹69.12Cr (↓66.81%)-₹429.43Cr (↑521.28%)

Index Inclusions

Nifty Smallcap 250

₹18,270.40

-1.11 (-205.4%)

Nifty 500

₹23,853.95

-0.19 (-44.7%)

S&P BSE 250 SmallCap

₹7,399.09

-1.01 (-75.19%)

BSE Healthcare

₹43,655.30

-0.25 (-108.18%)

S&P BSE 400 MidSmallCap

₹12,769.65

-0.61 (-78.92%)

Nifty MidSmallcap 400

₹20,684.65

-0.73 (-152.4%)

BSE Small-Cap

₹56,312.66

-1.06 (-603.27%)

BSE 500

₹37,616.67

-0.14 (-51.62%)

S&P BSE AllCap

₹11,001.59

-0.22 (-24.68%)

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
65.67%
0.00
Foreign Institutions
2.64%
-18.38
Mutual Funds
0.08%
-68.52
Retail Investors
31.51%
4.06
Others
0.1%
-81.88

Key Indicators

Details2024
Return On Assets %-79.62
Details2024
Book Value Per Share (₹)3.88
Details2024
Earning Per Share (₹)-11.93

Sun Pharma Advanced Research Company Ltd Valuation

Sun Pharma Advanced Research Company Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-38.16x)

April 8, 2024

Today (-18.39x)

September 18, 2024

Industry (58.50x)

September 18, 2024

Highest (0.00x)

December 29, 2023

LowHigh

Earnings and Dividends

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit fell -0.58% since last year same period to ₹-95.90Cr in the Q1 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 9.35% jump in its net profits since last 3-months.

    Read More about Earnings Results

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Sun Pharma Advanced Research Company Ltd is currently in a Bearish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Sun Pharma Advanced Research Company Ltd shares.

Sun Pharma Advanced Research Company Ltd (SPARC) share price today is ₹218.25

Sun Pharma Advanced Research Company Ltd is listed on NSE

Sun Pharma Advanced Research Company Ltd is listed on BSE

  • Today’s highest price of Sun Pharma Advanced Research Company Ltd is ₹221.9.
  • Today’s lowest price of Sun Pharma Advanced Research Company Ltd is ₹215.26.

PE Ratio of Sun Pharma Advanced Research Company Ltd is -18.39

PE ratio = Sun Pharma Advanced Research Company Ltd Market price per share / Sun Pharma Advanced Research Company Ltd Earnings per share

Today’s traded volume of Sun Pharma Advanced Research Company Ltd(SPARC) is 6.30L.

Today’s market capitalisation of Sun Pharma Advanced Research Company Ltd(SPARC) is ₹7131.04Cr.

Sun Pharma Advanced Research Company Ltd(SPARCPrice
52 Week High
₹472.8
52 Week Low
₹196.1

Sun Pharma Advanced Research Company Ltd(SPARC) share price is ₹218.25. It is down -53.84% from its 52 Week High price of ₹472.8

Sun Pharma Advanced Research Company Ltd(SPARC) share price is ₹218.25. It is up 11.30% from its 52 Week Low price of ₹196.1

Sun Pharma Advanced Research Company Ltd(SPARCReturns
1 Day Returns
-1.49%
1 Month Returns
3.41%
3 Month Returns
-5.68%
1 Year Returns
-5.02%